Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Besra OZMEN YELKEN"'
Autor:
Serra Kamer, Sunde Yilmaz Susluer, Tugce Balci Okcanoglu, Cagla Kayabasi, Besra Ozmen Yelken, Sinan Hoca, Emin Tavlayan, Nezahat Olacak, Yavuz Anacak, Murat Olukman, Cumhur Gunduz
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19874-19888 (2023)
Abstract Background The optimal radiobiological model, which assesses the biological effects of novel radiotherapy techniques that concurrently modify multiple physical factors, has not yet been defined. This study aimed to investigate the impact of
Externí odkaz:
https://doaj.org/article/e17e509ce1f94a338df322216105b111
Autor:
Sunde Yılmaz Susluer, Cagla Kayabasi, Besra Ozmen Yelken, Aycan Asik, Didem Celik, Tugce Balci Okcanoglu, Suheyla Serin Senger, Cigir Biray Avci, Sukran Kose, Cumhur Gunduz
Publikováno v:
Biomolecules & Biomedicine, Vol 18, Iss 2 (2018)
Long non-coding RNAs (lncRNAs) have been implicated in numerous biological processes, including epigenetic regulation, cell-cycle control, and transcriptional/translational regulation of gene expression. Differential expression of lncRNAs and disrupt
Externí odkaz:
https://doaj.org/article/dd202106ed8541fdbdb952f0eef8a374
Autor:
Pelin TAŞTAN, Tuğçe FAFAL, Burcu SÜMER TÜZÜN, Besra OZMEN YELKEN, Cağla KAYABASI, Sunde YILMAZ SUSLUER, Cumhur GUNDUZ, Bijen KIVCAK
Publikováno v:
Journal of Research in Pharmacy. 27:1242-1251
Autor:
Cagla Kayabasi, Sunde Yilmaz Susluer, Tugce Balci Okcanoglu, Besra Ozmen Yelken, Zeynep Mutlu, Bakiye Goker Bagca, Cansu Caliskan Kurt, Guray Saydam, Cenk Durmuskahya, Husniye Kayalar, Ahmet Ozbilgin, Cigir Biray Avci, Cumhur Gunduz
Publikováno v:
Nutrition and Cancer. 74:3679-3691
Origanum sipyleum is used in folk medicine due to its anti-inflammatory, antimicrobial, and antioxidant properties. Ponatinib, an effective tyrosine kinase inhibitor in the treatment of chronic myeloid leukemia (CML), has severe side effects. Thus, w
Autor:
Besra Ozmen Yelken, Bijen Kivçak, Pelin Taştan, Sunde Yilmaz Susluer, Tugce Fafal, Burcu Sümer Tüzün, Cumhur Gündüz, Cagla Kayabasi
Publikováno v:
Green Processing and Synthesis, Vol 9, Iss 1, Pp 153-163 (2020)
ASP was used to synthesize FeNPA. They were characterized by UV-vis spectroscopy, FT-IR, TEM, SEM, XRD and ZP. The aim of this study was to evaluate in vitro cytotoxic activity and antioxidant acitivities of FeNPA and ASP. The antioxidant properties
Autor:
Cagla Kayabasi, Ayse Caner, Sunde Yilmaz Susluer, Tugce Balci Okcanoglu, Besra Ozmen Yelken, Aycan Asik, Zeynep Mutlu, Cansu Caliskan Kurt, Bakiye Goker Bagca, Cigir Biray Avci, Fahri Sahin, Guray Saydam, Cumhur Gunduz
Publikováno v:
Medical oncology (Northwood, London, England). 39(3)
LncRNAs are associated with malignancies with their tumor suppressor/oncogenic properties. Although many studies are conducted related to the mechanism of action for dasatinib and ponatinib in chronic myeloid leukemia (CML), their comparative effects
Autor:
Sunde Yilmaz Susluer, Besra Ozmen Yelken, Tugce Balci, Cagla Kayabasi, Cumhur Gündüz, Bakiye Goker Bagca, Cigir Biray Avci, Cansu Caliskan Kurt, Zeynep Mutlu
Bu çalışma, 30 Ağustos - 4 Eylül 2014 tarihleri arasında Paris[Fransa]'de düzenlenen 39th Congress of the Federation of European Biochemical Societies (FEBS) EMBO 2014 Conference'de ve 28-31 Ekim 2021 tarihlerinde düzenlenen XVII. Tıbbi Biyo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a29ec976755d6e71a6390f2ab735fb9
http://hdl.handle.net/11452/27469
http://hdl.handle.net/11452/27469
Autor:
Roya Gasimli, Sunde Yilmaz Susluer, Güray Saydam, Fatma Sogutlu, Tugce Balci Okcanoglu, Cagla Kayabasi, Cigir Biray Avci, Aycan Asik, Cumhur Gündüz, Besra Ozmen Yelken
Publikováno v:
European journal of pharmacology. 910
Ponatinib is used for advanced treatment of chronic myeloid leukemia (CML), although low doses to prevent side effects do not suppress survival pathways and eradicate leukemia stem cells (LSCs). We evaluated the potential of ponatinib and PI3K/mTOR d
Autor:
Cigir Biray Avci, Fatma Sogutlu, Cagla Kayabasi, Sunde Yilmaz Susluer, Besra Ozmen Yelken, Sezgi Kipcak, Aycan Asik, Roya Gasimli, Cumhur Gündüz
Background: Dysregulation of the cell cycle is one of the main causes of melanomagenesis. Genomewide studies showed that the expression of Aurora -A and -B significantly has been upregulated in melanoma. However, there is no FDA approved drug targeti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b5b8776390dd1331d7a8cec3d556cc0
https://hdl.handle.net/11454/78173
https://hdl.handle.net/11454/78173
Autor:
Aycan Asik, Besra Ozmen Yelken, Cagla Kayabasi, Cigir Biray Avci, Fatma Dogan, Cumhur Gündüz, Fatma Sogutlu, Sunde Yilmaz Susluer, Roya Gasimli
Publikováno v:
Journal of Cellular Biochemistry. 120:380-395
The effect of Wnt pathway in head and neck cancer could not be elucidated, even though the aberrant Wnt signaling plays a key role in the development of many types of cancer. The inhibitor of β-catenin responsive transcription (ICRT-3) blocks the Wn